RIGL

MKT CAP:$552M

Rigel Pharmaceuticals Inc

Market Cap

$552M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$29.93-$11.90 (-28.45%)

Jun 5, 2026

52W High $50.9652W Low $18.42

Company Details

Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinas...

CEO

—

IPO Date

Nov 29, 2000

Website

www.rigel.com

Key Metrics TTM

Revenue

$300M

+47.6% YoY

Net Income

$364M

EPS (Diluted)

Free Cash Flow

$79M

Revenue / Share

$15.23

Gross Margin

93.4%

Operating Margin

41.6%

Net Margin

121.5%

FCF Margin

26.4%

P/S

1.8x

P/E

1.5x

Earnings Reports

Q2 2026

Aug 4, 2026

PENDING

Q1 2026

May 5, 2026

$59M+10.3%

FY 2025

Mar 3, 2026

$294M+64.1%

Q4 2025

Mar 3, 2026

$70M+21.2%

Q3 2025

Nov 4, 2025

$69M+25.6%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee